ArticleDrug and alcohol dependence2025
Naltrexone blocks the sleep-disrupting effects of methamphetamine in male rhesus monkeys.
Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMethamphetamine has garnered increasing attention due to its escalating recreational use resulting in significant morbidity and mortality. Methamphetamine also significantly alters sleep quality, a finding that has been observed in both human and non-human primates. Naltrexone, an opioid receptor antagonist used in the treatment of opioid and alcohol use disorder, has shown promise as a treatment for methamphetamine use disorder. However, the potential benefits of naltrexone with regards to ameliorating sleep disturbances associated with methamphetamine use are unknown. The aim of the present study was to investigate the acute effects of evening naltrexone administration on the acute sleep-disrupting effects of methamphetamine.
methodsAdult male rhesus macaques (N = 4) were fitted with primate collars to which actigraphy monitors were attached. Vehicle or naltrexone (0.03, 0.1, and 0.3mg/kg, i.m.) were administered in the evening (ZT10.5, 1.5h before "lights off") following a morning (ZT4, 4h after "lights on") administration of methamphetamine (0.3mg/kg, i.m.).
resultsOur findings replicate previous studies showing that methamphetamine significantly impairs sleep-associated measures in male rhesus monkeys, increasing actigraphy-based measures of sleep latency and wake time after sleep onset (WASO), and decreasing sleep efficiency. Evening treatment with naltrexone dose-dependently improved methamphetamine-induced sleep impairment, with the highest dose significantly improving actigraphy-based measures of sleep latency, sleep efficiency, and WASO.
conclusionsThese results suggest that naltrexone may be beneficial in the treatment of methamphetamine use disorder through amelioration of sleep disturbances observed with methamphetamine use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.